BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 11464906)

  • 1. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
    Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
    Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
    Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
    Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
    Hogarty MD; Winter CL; Liu X; Guo C; White PS; Look AT; Brodeur GM; Maris JM
    Cancer Res; 2002 Nov; 62(22):6481-4. PubMed ID: 12438240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
    Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig.
    Bauer A; Savelyeva L; Claas A; Praml C; Berthold F; Schwab M
    Genes Chromosomes Cancer; 2001 Jul; 31(3):228-39. PubMed ID: 11391793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
    Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
    Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T
    Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted.
    Caron H; Spieker N; Godfried M; Veenstra M; van Sluis P; de Kraker J; Voûte P; Versteeg R
    Genes Chromosomes Cancer; 2001 Feb; 30(2):168-74. PubMed ID: 11135433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.
    Spieker N; Beitsma M; Van Sluis P; Chan A; Caron H; Versteeg R
    Genes Chromosomes Cancer; 2001 Jun; 31(2):172-81. PubMed ID: 11319804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
    Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
    Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
    Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
    Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
    Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F
    Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
    Maris JM; Guo C; White PS; Hogarty MD; Thompson PM; Stram DO; Gerbing R; Matthay KK; Seeger RC; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):24-7. PubMed ID: 11464895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
    Cheng JM; Hiemstra JL; Schneider SS; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
    Nat Genet; 1993 Jun; 4(2):191-4. PubMed ID: 8102299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
    Guo C; White PS; Weiss MJ; Hogarty MD; Thompson PM; Stram DO; Gerbing R; Matthay KK; Seeger RC; Brodeur GM; Maris JM
    Oncogene; 1999 Sep; 18(35):4948-57. PubMed ID: 10490829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
    Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
    Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
    Gehring M; Berthold F; Edler L; Schwab M; Amler LC
    Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.